Authors: Westermann, J Reich, G Kopp, J Haus, U Dorken, D Pezzutto, A

Citation: J. Westermann et al., Granulocyte/macrophage-colony-stimulating-factor plus interleukin-2 plus interferon alpha in the treatment of metastatic renal cell carcinoma: a pilot study, CANCER IMMU, 49(11), 2001, pp. 613-620

Authors: Strata, T Farber, L Varga, B Haus, U Baumgartner, C Muller, W

Citation: T. Strata et al., Treatment of fibromyalgia with intravenous application of tropisetron, J MUSCULO P, 8(4), 2000, pp. 31-40

Authors: Haus, U Varga, B Stratz, T Spath, M Muller, WG

Citation: U. Haus et al., Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain, SC J RHEUM, 29, 2000, pp. 55-58

Authors: Muller, W Pongratz, D Barlin, E Eich, W Farber, L Haus, U Lautenschlager, J Mense, S Neeck, G Offenbacher, M Spath, M Stratz, T Tolk, J Welzel, D Wiech, K Wohlgemuth, M

Citation: W. Muller et al., The challenge of fibromyalgia: new approaches, SC J RHEUM, 29, 2000, pp. 86-86

Authors: Sulkowski, U Buchler, M Pederzoli, P Arnold, R Dinse, P Kay, A Haus, U Beger, HG

Citation: U. Sulkowski et al., A phase II study of high-dose octreotide in patients with unresectable pancreatic carcinoma, EUR J CANC, 35(13), 1999, pp. 1805-1808

Authors: Wagner, W Alfrink, M Haus, U Matt, J

Citation: W. Wagner et al., Treatment of irradiation-induced mucositis with growth factors (rhGM-CSF) in patients with head and neck cancer, ANTICANC R, 19(1B), 1999, pp. 799-803